These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34236433)

  • 21. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
    Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
    J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Tobacco Smoke Exposure in Utero and Concentrations of Hepcidin and Selected Iron Parameters in Newborns.
    Chełchowska M; Maciejewski TM; Mazur J; Gajewska J; Zasimovich A; Ołtarzewski M; Ambroszkiewicz J
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31195607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoassay for human serum erythroferrone.
    Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
    Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
    Youssry I; Samy RM; AbdelMohsen M; Salama NM
    Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
    Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
    Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
    Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
    Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
    Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
    Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
    Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
    Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia.
    Li Y; Miller I; Prasad P; George NA; Parrow NL; Fleming RE
    Front Physiol; 2022; 13():893149. PubMed ID: 35634155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients.
    Smesam HNK; Albuthabhak HAQ; Arjmand S; Al-Hakeim HK; R Siadat SO
    Hemoglobin; 2020 Jul; 44(4):272-277. PubMed ID: 32718192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
    Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin as a potential biomarker for blood doping.
    Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
    Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
    Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythroferrone as a sensitive biomarker to detect stimulation of erythropoiesis.
    Ramirez Cuevas K; Schobinger C; Gottardo E; Voss SC; Kuuranne T; Tissot JD; Favrat B; Townsend N; Leuenberger N
    Drug Test Anal; 2020 Feb; 12(2):261-267. PubMed ID: 31655016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythroferrone inhibits the induction of hepcidin by BMP6.
    Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum erythroferrone levels during the first month of life in premature infants.
    Lenhartová N; Ochiai M; Sawano T; Yasuoka K; Fujiyoshi J; Inoue H; Ohga S
    J Perinatol; 2022 Jan; 42(1):97-102. PubMed ID: 34376791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency.
    Zaninoni A; Marra R; Fermo E; Consonni D; Andolfo I; Marcello AP; Rosato BE; Vercellati C; Barcellini W; Iolascon A; Bianchi P; Russo R
    Sci Rep; 2023 Mar; 13(1):4395. PubMed ID: 36927785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythroferrone contributes to iron mobilization for embryo erythropoiesis in iron-deficient mouse pregnancies.
    Sangkhae V; Yu V; Coffey R; O'Brien KO; Ganz T; Nemeth E
    Am J Hematol; 2022 Oct; 97(10):1348-1358. PubMed ID: 36071577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    El-Gamal RAE; Abdel-Messih IY; Habashy DM; Zaiema SEG; Pessar SA
    Ann Hematol; 2020 Jan; 99(1):31-39. PubMed ID: 31834456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
    Olivera J; Zhang V; Nemeth E; Ganz T
    Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.